Adrienn Kis

727 total citations
21 papers, 371 citations indexed

About

Adrienn Kis is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adrienn Kis has authored 21 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adrienn Kis's work include Peptidase Inhibition and Analysis (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Cell Adhesion Molecules Research (4 papers). Adrienn Kis is often cited by papers focused on Peptidase Inhibition and Analysis (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Cell Adhesion Molecules Research (4 papers). Adrienn Kis collaborates with scholars based in Hungary, United Kingdom and Canada. Adrienn Kis's co-authors include Derek M. Yellon, Gary F. Baxter, György Trencsényi, Julius Gy. Papp, James R. Parratt, István Kertész, Gábor Mező, Ágnes Végh, Ildikó Garai and Gábor Nagy and has published in prestigious journals such as British Journal of Pharmacology, International Journal of Pharmaceutics and Cardiovascular Research.

In The Last Decade

Adrienn Kis

21 papers receiving 366 citations

Peers

Adrienn Kis
Stephen C. Lenhard United States
Meredith L. Rees United States
Brendan Quinn United States
Sarath Meduru United States
Yingai J. Jin United States
Jason Wall United States
Katelyn Powell United States
Adrienn Kis
Citations per year, relative to Adrienn Kis Adrienn Kis (= 1×) peers Olivia Beseme

Countries citing papers authored by Adrienn Kis

Since Specialization
Citations

This map shows the geographic impact of Adrienn Kis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienn Kis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienn Kis more than expected).

Fields of papers citing papers by Adrienn Kis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienn Kis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienn Kis. The network helps show where Adrienn Kis may publish in the future.

Co-authorship network of co-authors of Adrienn Kis

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienn Kis. A scholar is included among the top collaborators of Adrienn Kis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienn Kis. Adrienn Kis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kis, Adrienn, Gábor Opposits, Ferenc K. Kálmán, et al.. (2024). Acute Myelomonoblastic Leukemia (My1/De): A Preclinical Rat Model. In Vivo. 38(3). 1064–1073. 1 indexed citations
2.
Kis, Adrienn, Gábor Opposits, László Balkay, et al.. (2022). In VivoImaging of Ischemia/Reperfusion-mediated Aminopeptidase N Expression in Surgical Rat Model Using68Ga-NOTA-c(NGR). In Vivo. 36(2). 657–666. 3 indexed citations
3.
Kis, Adrienn, Gábor Opposits, István Hajdu, et al.. (2022). In VivoImaging of Neo-angiogenesis of Transplanted Metastases in Subrenal Capsule Assay Induced Rat Model. In Vivo. 36(4). 1667–1675. 4 indexed citations
4.
Kis, Adrienn, Gábor Nagy, Ildikó Garai, et al.. (2022). Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe. Pharmaceuticals. 15(6). 666–666. 6 indexed citations
5.
Kis, Adrienn, et al.. (2021). Synthesis of 68Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging. Pharmaceutics. 13(12). 2103–2103. 6 indexed citations
6.
Kis, Adrienn, István Hajdu, Gábor Mező, et al.. (2021). In vivo preclinical assessment of novel 68Ga-labelled peptides for imaging of tumor associated angiogenesis using positron emission tomography imaging. Applied Radiation and Isotopes. 174. 109778–109778. 6 indexed citations
7.
Kis, Adrienn, Lívia Beke, Gábor Méhes, et al.. (2021). In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68Ga‐NODAGA‐c(NGR) Peptide. BioMed Research International. 2021(1). 6642973–6642973. 11 indexed citations
8.
Kis, Adrienn, et al.. (2020). In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging. International Journal of Pharmaceutics. 589. 119881–119881. 15 indexed citations
9.
Kis, Adrienn, Gábor Nagy, Ildikó Garai, et al.. (2020). In Vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography. BioMed Research International. 2020(1). 4952372–4952372. 5 indexed citations
10.
Kis, Adrienn, Pál Mikecz, Péter Mátyus, et al.. (2020). Radiosynthesis and Preclinical Investigation of 11C‐Labelled 3‐(4,5‐Diphenyl‐1,3‐oxazol‐2‐yl)propanal Oxime ([11C]SZV 1287). ChemMedChem. 15(24). 2470–2476. 3 indexed citations
11.
Kertész, István, András Vida, Gábor Nagy, et al.. (2017). In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer 68Ga-NODAGA-Procainamide (PCA). Journal of Cancer. 8(5). 774–785. 14 indexed citations
12.
Trencsényi, György, Gábor Nagy, Adrienn Kis, et al.. (2017). Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging. Journal of Pharmaceutical and Biomedical Analysis. 139. 54–64. 16 indexed citations
13.
Nagy, Gábor, Adrienn Kis, Ervin Berényi, et al.. (2017). Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific 68Ga- and 44Sc-labeled DOTA-NAPamide in melanoma imaging. European Journal of Pharmaceutical Sciences. 106. 336–344. 29 indexed citations
14.
Kertész, István, Gábor Mező, Adrienn Kis, et al.. (2015). In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer 68Ga-NOTA-c(NGR). European Journal of Pharmaceutical Sciences. 69. 61–71. 43 indexed citations
15.
Gurung, Iman S., Gema Medina‐Gómez, Adrienn Kis, et al.. (2011). Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia. Cardiovascular Research. 92(1). 29–38. 27 indexed citations
16.
Kis, Adrienn, Colin E. Murdoch, Min Zhang, et al.. (2009). Defective Peroxisomal Proliferators Activated Receptor Gamma Activity Due to Dominant-Negative Mutation Synergizes with Hypertension to Accelerate Cardiac Fibrosis in Mice. European Journal of Heart Failure. 11(6). 533–541. 33 indexed citations
17.
Kis, Adrienn, Gary F. Baxter, & Derek M. Yellon. (2003). Limitation of Myocardial Reperfusion Injury by AMP579, an Adenosine A1/A2A Receptor Agonist: Role of A2A Receptor and Erk1/2. Cardiovascular Drugs and Therapy. 17(5-6). 415–425. 45 indexed citations
18.
Kis, Adrienn, Derek M. Yellon, & Gary F. Baxter. (2003). Role of nuclear factor‐κB activation in acute ischaemia‐reperfusion injury in myocardium. British Journal of Pharmacology. 138(5). 894–900. 47 indexed citations
19.
Kis, Adrienn, et al.. (1999). Pacing‐induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. British Journal of Pharmacology. 127(7). 1545–1550. 23 indexed citations
20.
Kis, Adrienn, Ágnes Végh, Julius Gy. Papp, & James R. Parratt. (1999). Repeated Cardiac Pacing Extends the Time During Which Canine Hearts are Protected Against Ischaemia-induced Arrhythmias: Role of Nitric Oxide. Journal of Molecular and Cellular Cardiology. 31(6). 1229–1241. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026